Answers are grounded in this paper and cite their sources.
During the past decade a lot of work has been done to better understand the roles of fibroblast growth factor-23 (FGF-23); a relatively newly discovered endocrine hormone, in multiple organ systems in the body. This review focuses on expressions of FGF-23, coexpressions of -Klotho and FGF receptors, and FGF-23 mediated end-organ effects in the physiological and pathological conditions. We also discuss the controversial reports regarding -Klotho-dependent and -Klotho-independent functions of FGF-23.
No takes yet. Share an insight, caveat, or question.
Nayani et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: